Rating Change
HC Wainwright & Co. analysts reiterated a Neutral rating on Aardvark Therapeutics, Inc. Common Stock (NASDAQ:AARD) on July 20, 2026.
Rating Change HC Wainwright & Co. analysts reiterated a Neutral rating on Aardvark Therapeutics, Inc. Common Stock (NASDAQ:AARD) on July 20, 2026.

HC Wainwright & Co. analysts reiterated a Neutral rating on Aardvark Therapeutics, Inc. Common Stock (NASDAQ:AARD) on July 20, 2026.
Aardvark Therapeutics, Inc. Common Stock operates in the Healthcare sector. The stock currently trades at $5.58 with a market capitalization of $271.9M. The stock has declined 49.5% over the past 52 weeks.
Analyst coverage from HC Wainwright & Co. provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Aardvark Therapeutics, Inc. Common Stock.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 4 Buy, 5 Hold, 1 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 20, 2026 | HC Wainwright & Co. | Neutral | N/A |
| May 15, 2026 | Morgan Stanley | Underweight | N/A |
| May 15, 2026 | B. Riley Securities | Buy | N/A |
| May 15, 2026 | BTIG | Neutral | N/A |
| Mar 24, 2026 | BTIG | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View AARD Stock Page
A Neutral rating from HC Wainwright & Co. reflects the analyst's outlook on Aardvark Therapeutics, Inc. Common Stock (NASDAQ:AARD). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the AARD forecast page.
Current market data
NASDAQ · AARD
$5.38
Down: -$0.35 · -6.11%
Live quote updated
Keep reading
earnings ·
price ·
price ·
sec_filing ·